A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Increases Dendritic Spine Density via RasGRF1/ERK Pathway-Reference-Cited by-同舟云学术

A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Increases Dendritic Spine Density via RasGRF1/ERK Pathway

Author:

Song Jung Min¹,Sung You Me¹,Nam Jin Han²,Yoon Hyejin³,Chung Andrew¹,Moffat Emily¹,Jung Mira⁴,Pak Daniel T.S.⁵,Kim Jungsu³,Hoe Hyang-Sook¹²

Affiliation:

1. Department of Neuroscience, Georgetown University Medical Center, Washington, DC, USA

2. Department of Neural Development and Disease, Korea Brain Research Institute (KBRI), Dong-gu, Daegu, Korea

3. Department of Neuroscience, Neurobiology of Disease Graduate Program, Mayo Graduate School, Mayo Clinic College of Medicine, Jacksonville, FL, USA

4. Department of Radiation Medicine, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA

5. Department of Pharmacology, Georgetown University Medical Center, Washington, DC, USA

Publisher

IOS Press

Subject

Psychiatry and Mental health,Geriatrics and Gerontology,Clinical Psychology,General Medicine,General Neuroscience

Reference35 articles.

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献